Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 151.8
(1.88%)
SAR 151.8
(1.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.1 Billion | 916.67 Million | 735.68 Million | 805.31 Million | 731.73 Million | 701.3 Million |
| Cost of Revenue | 397 Million | 322.74 Million | 260.98 Million | 292.01 Million | 312.3 Million | 263 Million |
| Gross Profit | 703.81 Million | 593.92 Million | 474.69 Million | 513.29 Million | 419.43 Million | 438.29 Million |
| Operating Expenses | 388.36 Million | 350.61 Million | 288.89 Million | 273.38 Million | 244.89 Million | 266.42 Million |
| Selling, General and Administrative Expenses | 352.47 Million | 171.17 Million | 137.66 Million | 135.33 Million | 244.89 Million | 266.42 Million |
| Research and Development Expenses | 33.38 Million | 32.68 Million | 37 Million | 36.48 Million | - | - |
| Other Expenses | 2.5 Million | 4.83 Million | 4.46 Million | 980.5 Thousand | - | - |
| Cost and Expenses | 787.43 Million | 673.36 Million | 549.88 Million | 565.4 Million | 557.19 Million | 529.43 Million |
| Operating Income | 313.37 Million | 233.32 Million | 186.75 Million | 248.13 Million | 174.53 Million | 171.86 Million |
| Interest Expense | 627.21 Thousand | 122.26 Thousand | 3.18 Million | - | - | - |
| Income Tax Expense | 23.39 Million | 15 Million | 17.39 Million | 24.88 Million | 18.73 Million | 15.39 Million |
| Earnings before Tax | 315.79 Million | 186.31 Million | 188.08 Million | 231.74 Million | 175.67 Million | 166.23 Million |
| Net Income | 292.4 Million | 171.31 Million | 170.69 Million | 206.86 Million | 156.93 Million | 150.83 Million |
| Earnings Per Share Basic | 4.18 | 2.45 | 2.44 | 2.96 | 2.24 | 2.15 |
| Earnings Per Share Diluted | 4.18 | 2.45 | 2.44 | 2.96 | 2.24 | 2.15 |
| Weighted Average Shares Outstanding | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
| Weighted Average Shares Outstanding (Diluted) | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
| Gross Margin | 0.64 | 0.65 | 0.65 | 0.64 | 0.57 | 0.62 |
| EBIT Margin | 0.31 | 0.24 | 0.29 | 0.36 | 0.30 | 0.31 |
| Profit Margin | 0.27 | 0.19 | 0.23 | 0.26 | 0.21 | 0.22 |
| EBITDA | 338.64 Million | 212.22 Million | 215.67 Million | 281.87 Million | 216.36 Million | 213.91 Million |
| Earnings Before Tax Margin | 0.28 | 0.25 | 0.25 | 0.31 | 0.24 | 0.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 327.58 Million | 345.73 Million | 385.46 Million | 1.1 Billion | 207.9 Million | 292.61 Million |
| Cost of Revenue | 133.16 Million | 127.55 Million | 136.05 Million | 397 Million | 89 Million | 105.38 Million |
| Gross Profit | 194.41 Million | 218.18 Million | 249.4 Million | 703.8 Million | 118.9 Million | 187.22 Million |
| Operating Expenses | 98.74 Million | 113.92 Million | 122.81 Million | 390.4 Million | 76.7 Million | 98.34 Million |
| Selling, General and Administrative Expenses | - | 106.49 Million | 110.78 Million | - | -87.89 Million | 89.72 Million |
| Research and Development Expenses | - | 7.42 Million | 8.12 Million | - | 7.39 Million | 8.61 Million |
| Other Expenses | -98.74 Million | 694.11 Thousand | -122.81 Million | -390.4 Million | -76.7 Million | 346.93 Thousand |
| Cost and Expenses | 231.91 Million | 241.47 Million | 258.87 Million | 787.4 Million | 165.7 Million | 203.73 Million |
| Operating Income | 95.67 Million | 104.25 Million | 126.58 Million | 313.4 Million | 42.2 Million | 84.67 Million |
| Interest Expense | - | 24.84 Thousand | 27.38 Thousand | 112.08 Thousand | 27.35 Thousand | 27.25 Thousand |
| Income Tax Expense | -94.99 Million | 3.24 Million | 9.76 Million | 23.39 Million | 2.62 Million | 6.61 Million |
| Earnings before Tax | - | 108.18 Million | 112.73 Million | 315.79 Million | 47.1 Million | 83.85 Million |
| Net Income | 94.99 Million | 106.95 Million | 102.96 Million | 292.4 Million | 44.48 Million | 77.24 Million |
| Earnings Per Share Basic | 1.36 | 1.53 | 1.47 | - | 0.60 | 1.10 |
| Earnings Per Share Diluted | 1.36 | 1.53 | 1.47 | - | 0.64 | 1.10 |
| Weighted Average Shares Outstanding | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
| Weighted Average Shares Outstanding (Diluted) | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
| Gross Margin | 0.59 | 0.63 | 0.65 | 0.64 | 0.57 | 0.64 |
| EBIT Margin | 0.29 | 0.33 | 0.32 | - | 0.25 | 0.32 |
| Profit Margin | 0.29 | 0.31 | 0.27 | 0.27 | 0.21 | 0.26 |
| EBITDA | 95.67 Million | 114.03 Million | 124.28 Million | - | 51.87 Million | 94.77 Million |
| Earnings Before Tax Margin | 0.29 | 0.30 | 0.33 | 0.28 | 0.20 | 0.29 |
0HBQ
0QZF
NXL
TPRKY
7538
QPM